The future home of the state’s first freestanding cancer hospital is taking shape in downtown New Brunswick, where a crowd of business and political leaders gathered Wednesday to tout the progress of the city’s largest and most impactful development project to date.
On the money
I’ve spent a decade watching Devco tackle some of the state’s largest, most ambitious redevelopment projects with complex capital stacks and broad coalitions of stakeholders. It’s a topic that we feature in this month’s cover story, which follows a year in which the organization broke ground on more than $1.5 billion worth of development. That makes it all the more timely for us to highlight an operation that is seemingly unlike any other developer in New Jersey.
New Jersey needs turnkey lab space, faster approvals to compete for life sciences users
Experts say New Jersey faces a growing challenge: While it’s still a major draw for pharmaceutical research and development, speed to market has become increasingly important to life sciences users. That means the state’s lack of move-in-ready lab space — and its lengthy approval process for new construction — puts it at a disadvantage to competing markets.
